138
Views
7
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Clinical phenotypes of a large Chinese multigenerational kindred with autosomal dominant familial ALS due to Ile149Thr SOD1 gene mutation

, , , , , , , , , , & show all
Pages 142-149 | Received 19 Jan 2006, Accepted 23 Mar 2006, Published online: 10 Jul 2009
 

Abstract

About 10% of amyotrophic lateral sclerosis (ALS) cases are familial. We identified a five‐generation Chinese family with autosomal dominant familial ALS (FALS). We performed a detailed family study, clinical and electromyographic validation, and SOD1, VEGF and CNTF mutation analyses. Forty‐five living members (16 affected) were studied and DNA samples collected. Genealogical data were collected for deceased members. Based on the duration between symptom onset to ventilator dependence, they were divided into rapidly progressive (range 1–18 months, mean (SD) duration = 12.08 (±6.10) months, mean (SD) age of symptom onset = 39.75 (±9.84) years) and slowly progressive groups (>18 months; mean (SD) age of onset = 37.25 (±5.32) years old). We identified a heterozygous mutation of ATT to ACT of SOD1 gene at codon 149 in exon 5 resulting in substitution of isoleucine to threonine. It co‐segregated with all affected members and 11 non‐symptomatic members.

We report a large multigenerational Chinese FALS kindred with I149T mutation in SOD1. No polymorphisms or mutations were found to date in two known modifier genes, namely, VEGF and CNTF, which were associated with heterogeneity in the phenotype within this kindred. Follow‐up of the family will be helpful to explore any potential disease markers.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.